Catalyst Wire Dossier Catalyst Wire Dossier

Poziotinib

poziotinib · Spectrum Pharmaceuticals
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Poziotinib, covering 2016-03-01 to 2026-07-28. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib [Phase 2]

See pricing